Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarro, S.
Right arrow Articles by Vainchenker, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, S.
Right arrow Articles by Vainchenker, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication

S Navarro, N Debili, JP Le Couedic, B Klein, J Breton-Gorius, J Doly and W Vainchenker

INSERM U91, Hopital Henri Mondor, Creteil, France.

Interleukin-6 (IL-6) is a pleiotropic cytokine that plays an important role in the megakaryocytic differentiation. Recently, we have observed that IL-6 is synthesized by several human cell lines with megakaryocytic features. In this study, we have investigated whether a similar phenomenon occurs during normal megakaryocytic differentiation. Human megakaryocytes (MK) were obtained by culturing normal marrow in liquid culture with aplastic plasma (AP). First, an IL-6 secretion in bone marrow culture enriched in MK as well as in purified MK populations was demonstrated by a biologic assay. Second, IL-6 mRNA was detected in a purified population of MK by the polymerase chain reaction and dot blot analysis. IL-6 mRNA and protein were undetectable in platelets. Third, in situ hybridization procedure demonstrated the presence of IL-6 mRNA in individual immature MK. Fourth, IL-6 protein was detected in MK at the unicellular level by an immunoalkaline phosphatase technique using a monoclonal antibody against IL-6. Furthermore, the presence of IL-6 receptor (IL-6-R) on MK was demonstrated by in situ hybridization using an IL-6-R probe and in situ autoradiography after binding with [125I]-labeled recombinant IL-6. The IL-6 endogenously produced in liquid cultures containing normal human plasma or AP was subsequently neutralized. This resulted in a 50% decrease of the MK growth with a minor shift in the ploidy distribution toward lower values. In semisolid cultures the addition of anti-IL-6 antibodies led to a 42% decrease in colony number in cultures stimulated by IL-3 but not in other conditions of culture. These results suggest that normal human megakaryocytopoiesis might be regulated in part by an IL-6 autocrine loop.

Volume 77, Issue 3, pp. 461-471, 02/01/1991
Copyright © 1991 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
F. Al-Mohanna, S. Saleh, R. S. Parhar, K. Khabar, and K. Collison
Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed
J. Leukoc. Biol., July 1, 2005; 78(1): 51 - 61.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tomer
Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes
Blood, November 1, 2004; 104(9): 2722 - 2727.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. J. MacVittie, A. M. Farese, W. G. Smith, C. M. Baum, E. Burton, and J. P. McKearn
Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression
Blood, February 1, 2000; 95(3): 837 - 845.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J.-J. Li, L. W. Oberley, M. Fan, and N. H. Colburn
Inhibition of AP-1 and NF-{kappa}B by manganese-containing superoxide dismutase in human breast cancer cells
FASEB J, December 1, 1998; 12(15): 1713 - 1723.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
Y. Ishida, T. Ito, and S.-i. Kuriya
Effects of C-Mpl Ligand on Cytoplasmic Maturation of Murine Megakaryocytes and on Platelet Production
J. Histochem. Cytochem., January 1, 1998; 46(1): 49 - 58.
[Abstract] [Full Text]


Home page
BloodHome page
N. S. Weich, A. Wang, M. Fitzgerald, T. Y. Neben, D. Donaldson, J. Giannotti, J. Yetz-Aldape, R. M. Leven, and K. J. Turner
Recombinant Human Interleukin-11 Directly Promotes Megakaryocytopoiesis In Vitro
Blood, November 15, 1997; 90(10): 3893 - 3902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Ferry, S. B. Baliga, C. Monteiro, and B. S. Pace
Globin Gene Silencing in Primary Erythroid Cultures. AN INHIBITORY ROLE FOR INTERLEUKIN-6
J. Biol. Chem., August 8, 1997; 272(32): 20030 - 20037.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. E.J. Rasko, E. O'Flaherty, and C. G. Begley
Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors
Stem Cells, January 1, 1997; 15(1): 33 - 42.
[Abstract] [Full Text]


Home page
BloodHome page
L. A. Harker, U. M. Marzec, A. B. Kelly, E. Cheung, A. Tomer, J. L. Nichol, S. R. Hanson, and R. B. Stead
Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor
Blood, January 1, 1997; 89(1): 155 - 165.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1991 by American Society of Hematology         Online ISSN: 1528-0020